 
                    
                HYUNDAI BIOLAND Co.,Ltd.
Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.
052260 | KO
Overview
Corporate Details
- ISIN(s):
- KR7052260007
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청주시 흥덕구 오송읍 오송생명2로 22 SK 바이오랜드 오송공장, 청주시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
HYUNDAI BIOLAND Co., Ltd. is a comprehensive healthcare and biotechnology company specializing in the research, development, and manufacturing of biomaterials derived from natural resources. The company's core business operates across three main sectors: cosmetics, nutraceuticals (health supplements), and regenerative medicine. It is a key supplier of raw materials, including collagen and hyaluronic acid, to the cosmetics industry. In the nutraceuticals field, it provides functional ingredients for health foods. For the biomedical market, the company develops medical devices such as resorbable membranes for dental and periodontal tissue regeneration. Leveraging its position as a leading natural materials company in Korea, Hyundai Bioland distributes its products to over 35 countries, with safety certifications in 33 nations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 | Regulatory News Service 대규모기업집단현황공시[분기별공시(개별회사용)] | Korean | 7.7 KB | ||
| 2025-08-26 00:00 | Report Publication Announcement 기업설명회(IR)개최               | Korean | 6.7 KB | ||
| 2025-08-14 00:00 | Regulatory News Service 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 | Korean | 11.2 KB | ||
| 2025-08-14 00:00 | Interim Report 반기보고서 (2025.06) | Korean | 1.3 MB | ||
| 2025-08-04 00:00 | Earnings Release 연결재무제표기준영업(잠정)실적(공정공시)               | Korean | 16.3 KB | ||
| 2025-07-28 00:00 | Report Publication Announcement 결산실적공시예고               | Korean | 3.6 KB | ||
| 2025-05-30 00:00 | Major Shareholding Notification 대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)] | Korean | 134.8 KB | ||
| 2025-05-15 00:00 | Quarterly Report 분기보고서 (2025.03) | Korean | 1.1 MB | ||
| 2025-05-07 00:00 | Earnings Release 연결재무제표기준영업(잠정)실적(공정공시)               | Korean | 17.1 KB | ||
| 2025-04-30 00:00 | Regulatory News Service 소속부변경               | Korean | 3.6 KB | ||
| 2025-04-28 00:00 | Report Publication Announcement 결산실적공시예고               | Korean | 3.6 KB | ||
| 2025-03-19 00:00 | Post-Annual General Meeting Information 정기주주총회결과               | Korean | 33.4 KB | ||
| 2025-03-12 00:00 | Audit Report / Information [기재정정]감사보고서제출               | Korean | 30.3 KB | ||
| 2025-03-11 00:00 | Audit Report / Information 감사보고서제출               | Korean | 27.1 KB | ||
| 2025-03-11 00:00 | Audit Report / Information 사업보고서 (2024.12) | Korean | 467.3 KB | 
Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOLAND Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HYUNDAI BIOLAND Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HYUNDAI BIOLAND Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value | 
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
 
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                     
                                        
                                    